Expression of c-kit in human osteosarcoma and its relevance as a prognostic marker
- 3 October 2006
- journal article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 60 (7) , 804-807
Abstract
Aims: To examine the prognostic relevance of c-kit expression in human osteosarcomas and to evaluate the mutation status in exon 9 and exon 11 of the c-kit gene. Methods: c-kit expression was examined in 100 human osteosarcomas by immunohistochemistry using paraffin embedded tumour tissues, and capillary sequencing of genomic DNA was performed to search for mutations in exons 9 and 11 of the c-kit gene. Results: 20 osteosarcomas showed c-kit expression ranging from 5% to 90% (mean 5.9%; SD 16.74%). Furthermore, DNA sequences of exon 9 and exon 11 of the c-kit gene were not altered in these tumours. Overall and disease free survival analysis did not reveal any differences between patients with osteosarcoma with c-kit expression and those with c-kit negative tumours. Conclusions: C-kit expression is not a prognostic marker in patients with osteosarcoma. The protein expression is not linked to mutations in exon 9 or exon 11 of the c-kit gene. Therefore, these exons may not function as targets for treatment modalities based on the suppression of c-kit tyrosine kinase activity.Keywords
This publication has 21 references indexed in Scilit:
- TP53 Mutations and Outcome in Osteosarcoma: A Prospective, Multicenter StudyJournal of Clinical Oncology, 2005
- An Expression Signature Classifies Chemotherapy-Resistant Pediatric OsteosarcomaCancer Research, 2005
- Treatment of Gastrointestinal Stromal Tumors with Imatinib Mesylate:A Major Breakthrough in the Understanding of Tumor‐specific Molecular CharacteristicsWorld Journal of Surgery, 2005
- Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma GroupEuropean Journal of Cancer, 2004
- Evaluation of the predictive value of Her-2/neu gene expression on osteosarcoma therapy in laser-microdissected paraffin-embedded tissueLaboratory Investigation, 2004
- Growth inhibition of rat osteosarcoma and malignant fibrous histiocytoma cells by tyrosine kinase inhibitor STI571.2003
- Expression of Platelet-Derived Growth Factor-AA is Associated with Tumor Progression in OsteosarcomaLaboratory Investigation, 2003
- Imatinib Mesylate — A New Oral Targeted TherapyNew England Journal of Medicine, 2002
- Immunohistochemical Staining for KIT (CD117) in Soft Tissue Sarcomas Is Very Limited in DistributionAmerican Journal of Clinical Pathology, 2002
- Platelet-Derived Growth Factor-AA and -α Receptor Expression Suggests an Autocrine and/or Paracrine Loop in OsteosarcomaLaboratory Investigation, 2000